INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 418m ago
HOUSE PTR18m ago
SEC 13F18m ago
ROBINHOOD CHAIN18m ago
Public company

KZRKezar Life Sciences, Inc.

CIK 0001645666

EDGAR filingsOpen in network
Disclosed transactions35
Buys / sells0 / 0
Max Insider Score9
Connections5with evidence

KZR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Tender of shares
U—
2,711 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Chiang Pichi LuoSVP, Corporate Controller · May 11, 2026
  • ← Insider ofevidence
    Schiller Mark C.Chief Operating Officer · May 11, 2026
  • ← Insider ofevidence
    Klearman MickiDirector · May 11, 2026
9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D
—
10.0K sh
May 11, 2026
May 11, 2026
traded May 11, 2026
+0d
SEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
12.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
17.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
7,500 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
1,199 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
599 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,401 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,499 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,899 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,899 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
4,999 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
7,999 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Tender of shares
U—
2,739 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
25.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
24.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
12.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
4,999 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,499 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,249 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
11.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
13.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
16.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,000 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
3,500 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,000 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,200 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,600 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,600 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
WC
Wallace CourtneyDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
3,500 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
WC
Wallace CourtneyDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,000 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
WC
Wallace CourtneyDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,000 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
WC
Wallace CourtneyDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,200 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
WC
Wallace CourtneyDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,600 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,052 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Wallace CourtneyDirector · May 11, 2026
    • Source error

    Price history for KZR is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.